Clot Lysis Assay ? measurement of fibrinolysis in all parts of the reaction
At present, the fibrinolysis system is measured chromogenically via the enzyme activity of plasmin as a matter of routine. As the last reaction of fibrinolysis, i.e. the dissolution of fibrin strains, cannot be detected, this measurement system is only in part physiologi-cal.
The invention on hand provides a novel method rendering it possible to measure all steps of the fibrinolysis reaction, especially the dissolution of fibrin strain. Conventional microtiter plates containing micro thrombi are used in this novel clot lysis assay. Lysis is determined based on the regressing turbidity of the thrombus. Thereby, several different thrombolytic agents can be compared with each other. Both exogenic stimulation of plasmatic thrombolysis and intrinsic plasmatic thrombolysis of plasminogen activators can be measured. Experiments hitherto carried out with the novel clot lysis assay clearly indicate that different thrombolytic agents lead zu different clinical results, which most likely depend on endogenous thrombi.
Further Information: PDF
TransMIT Gesellschaft für Technologietransfer mbH
Phone: +49 (0)641/943 64-12
Contact
Dr. Peter Stumpf
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Parallel Paths: Understanding Malaria Resistance in Chimpanzees and Humans
The closest relatives of humans adapt genetically to habitats and infections Survival of the Fittest: Genetic Adaptations Uncovered in Chimpanzees Görlitz, 10.01.2025. Chimpanzees have genetic adaptations that help them survive…
You are What You Eat—Stanford Study Links Fiber to Anti-Cancer Gene Modulation
The Fiber Gap: A Growing Concern in American Diets Fiber is well known to be an important part of a healthy diet, yet less than 10% of Americans eat the minimum recommended…
Trust Your Gut—RNA-Protein Discovery for Better Immunity
HIRI researchers uncover control mechanisms of polysaccharide utilization in Bacteroides thetaiotaomicron. Researchers at the Helmholtz Institute for RNA-based Infection Research (HIRI) and the Julius-Maximilians-Universität (JMU) in Würzburg have identified a…